Mariner’s Arcadia Biosciences RKDA Stock Holding History

Mariner’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,264	Closed	-$42.6K	–	3762
2025 Q3	$42.6K	Sell	12,264 -2,236	-15%	-$9.14K	﹤0.01%	3466
2025 Q2	$62.5K	Sell	14,500 -12,981	-47%	-$51.3K	﹤0.01%	3314
2025 Q1	$81.6K	Buy	27,481 +2,481	+10%	+$10.7K	﹤0.01%	3224
2024 Q4	$148K	Hold	25,000	–	–	﹤0.01%	3094
2024 Q3	$68.3K	Buy	+25,000	New	+$71.7K	﹤0.01%	3151

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Mariner's RKDA Position: Q4 2025 in Review

Mariner sold out of Arcadia Biosciences (RKDA) in Q4 2025, closing a stake of 12,264 shares — an estimated $42.6K sold.

Mariner first reported a position in RKDA in Q3 2024 and held it in 5 quarters. The position peaked at $148K in Q4 2024. 13 funds tracked by Wall St. Rank hold RKDA as of Q4 2025.

Mariner reported no remaining Arcadia Biosciences position as of Q4 2025 after selling out during the quarter.
Mariner sold 12,264 Arcadia Biosciences shares in Q4 2025, an estimated $42.6K.
Mariner first reported a position in Arcadia Biosciences in Q3 2024 and held it in 5 quarters.
Mariner's Arcadia Biosciences position peaked at $148K in Q4 2024.
13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2025.

Based on Mariner's 13F filing for Q4 2025, filed 13 Feb 2026.